Sumalinog, Juryl B.

HRN: 22-08-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2022
CEFUROXIME 1.5GM (VIAL)
11/20/2022
11/26/2022
IVTT
1.5g On Call To OR Then 750mg
On Call To OR Then Q8
For Prophylaxis For Surgical Procedure
Waiting Final Action 
11/21/2022
CEFUROXIME 750MG (VIAL)
11/21/2022
11/26/2022
IVT
750mg
Q8 X 5 Days
S/P LTCS
Waiting Final Action 
11/21/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/21/2022
11/22/2022
IVT
500mg
Q8 X 3 Doses
S/P LTCS
Waiting Final Action 
11/21/2022
METRONIDAZOLE 500MG (TAB)
11/21/2022
11/26/2022
PO
500mg
Q8 X 5 Days
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: